Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial. Novartis ...

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

The cause of death has been confirmed for Michelle Trachtenberg, the 39-year-old actress who was found dead in a New York ...

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows ...

Merck MRK and AbbVie ABBV are leading pharmaceutical companies with strong portfolios in oncology and immunology. While ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks ...

Metabolic diseases is already a focus area for Merck & Co – it markets several diabetes drugs including Januvia (sitagliptin) and last year exercised an option to develop NGM313, an antibody ...

Merck KGaA is shaping up to take on Daiichi ... trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron. In a new pharmaphorum podcast, web editor ...

Creatine is a compound made from three amino acids that's found naturally in the body. Many people use creatine supplements ...